Main page content

Displaying results 11 - 16 of 16
Publication ID: SMA17-BAROUS-16
Published:

This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. The state-level Barometers contain valuable insight into the behavioral health needs and the unique challenges faced by communities across the country. This analysis can help public health authorities and others determine the best ways of meeting behavioral health care needs and disparities among various communities.

Publication ID: SMA13-4755PARTNERKIT
Published:

Provides parents of children ages 9 to 15 with the tools and information they need to start talking with their children early about the dangers of alcohol. Includes a suite of materials that helps reinforce the underage drinking prevention campaign's messages.

Publication ID: SMA15-4927
Published:

This NSDUH report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.

Publication ID: SMA14-4863
Published:

This report discusses results from a survey on the use of illicit substances, alcohol, and tobacco among people ages 12 years or older. It focuses on trends between 2012 and 2013 and from 2002 to 2013, as well as differences among population groups.

Publication ID: NSDUH14-0904
Published:

This report provides 2013 estimates on the prevalence of substance use disorder and mental illness in the United States. It also reports on the need for and barriers to substance use treatment, mental health care, and co-occurring substance use disorders and mental illness.

Publication ID: SMA10-4542
Published:

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.

Displaying 11 - 16 out of 16